Jeffrey Bluestone insider trades

Open-market stock purchases and sales by Jeffrey Bluestone, Director at Gilead Sciences, Inc, from SEC Form 4 filings since Mar 27, 2019.

Recent trades

DateStockTradeValue
Aug 20, 2026GILD Gilead Sciences, IncSold$49K
Aug 20, 2026GILD Gilead Sciences, IncBought (not open market)—
Aug 20, 2026GILD Gilead Sciences, IncBought (not open market)—
Aug 20, 2026GILD Gilead Sciences, IncBought (not open market)$78.6K
Aug 20, 2026GILD Gilead Sciences, IncSold$167K
Aug 20, 2026GILD Gilead Sciences, IncBought (not open market)$122K
Aug 20, 2026GILD Gilead Sciences, IncSold$263K
Aug 20, 2026GILD Gilead Sciences, IncBought (not open market)$112K
Aug 20, 2026GILD Gilead Sciences, IncSold$242K
Aug 20, 2026GILD Gilead Sciences, IncBought (not open market)$1.8K
Aug 20, 2026GILD Gilead Sciences, IncSold$3.8K
Apr 30, 2026GILD Gilead Sciences, IncBought (not open market)—
Apr 30, 2026GILD Gilead Sciences, IncBought (not open market)—
Jan 20, 2026GILD Gilead Sciences, IncSold$618K
Jan 20, 2026GILD Gilead Sciences, IncBought (not open market)—
Nov 28, 2025GILD Gilead Sciences, IncSold$625K
Nov 28, 2025GILD Gilead Sciences, IncBought (not open market)—

Companies traded

  • GILD Gilead Sciences, Inc: 9 sales, last Aug 20, 2026
  • PRVB Provention Bio, Inc: 1 sale, last May 17, 2022

Get free alerts when Jeffrey Bluestone files a new trade →